<DOC>
	<DOCNO>NCT01836198</DOCNO>
	<brief_summary>The purpose study examine effect gemfibrozil , ketoconazole , clarithromycin much LY2409021 find bloodstream long body take get rid . The study split two part , Part A Part B . Participants Part A divided two cohort ( group ) . Each cohort participate two study period . Period one involve single dose LY2409021 . Period two involve either gemfibrozil ketoconazole 21 day LY2409021 give Day 4 . Part A last 51 day also involve screen within 27 day start study . Part B open participant successfully complete Part A study . Participants Part B receive one single dose LY2409021 Day 4 clarithromycin 21 day . Part B last 29 day also involve screen within 27 day start study .</brief_summary>
	<brief_title>The Effect Gemfibrozil , Ketoconazole Clarithromycin Amount LY2409021 Bloodstream</brief_title>
	<detailed_description>Part B add trial August 2013 , per protocol amendment .</detailed_description>
	<mesh_term>Ketoconazole</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Gemfibrozil</mesh_term>
	<criteria>Participants overtly healthy male female , determine medical history physical examination Participants body mass index ( BMI ) 18.0 32.0 kilogram per meter square ( kg/m^2 ) , inclusive , screen Participants fast blood glucose 54 110 milligram per deciliter ( mg/dL ) ( 3.0 6.1 micromole per liter [ mmol/L ] ) Participants contraindication use clarithromycin Participants personal family history long QT syndrome Participants family history sudden unexplained death cardiac death immediate family member 60 year age Participants personal history unexplained syncope within last year Participants take drug substance know inducer inhibitor cytochrome P450 ( CYP ) 3A4 CYP2C8 CYP2J2 ( example , St. John 's wort , rifampin , ketoconazole , trimethoprim ) within 30 day prior first dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>